Tomáš B.
- Country
- Czechia
- Department
- Pracoviště MOTOL, Onkologická klinika 2. LF UK a FN Motol
Research Overview
- Phase I Study of XL092 Monotherapy and Combination Therapy in Advanced Solid Tumors: ccRCC, nccRCC, HR+ BC, mCRPC, and CRC
- Palazestrant and Ribociclib versus Letrozole and Ribociclib for First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Phase III Trial of BNT327 plus Combination Chemotherapy versus Placebo plus Chemotherapy in Patients with Previously Untreated Metastatic or Locally Recurrent Triple-Negative Breast Cancer
Data & Insights
Has run more than one trial at 546 of 883 partner sites.
Specializations
Urological Oncology
Specializes in advanced treatments for renal cell carcinoma, with particular focus on innovative combination therapies involving immune checkpoint inhibitors and targeted treatments.
- Metastatic Renal Cell Carcinoma
- Advanced Clear Cell Renal Cancer
- Adjuvant Therapy in RCC
Investigates novel therapeutic approaches in both first-line and subsequent treatment settings.
Prostate Cancer Research
Leads investigations in metastatic castration-resistant prostate cancer, exploring novel hormonal therapies and combination treatment approaches.
- Advanced Prostate Cancer
- Hormone-Sensitive Disease
- Biochemically Recurrent Disease
Focuses on developing treatment strategies for various stages of prostate cancer progression.
Bladder Cancer Studies
Conducts research in urothelial cancer treatment, particularly investigating immunotherapy combinations and targeted therapies.
- Muscle-Invasive Bladder Cancer
- Metastatic Urothelial Cancer
- Neoadjuvant Treatment Approaches
Evaluates novel therapeutic combinations for improved patient outcomes in bladder cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.